ERBB2 and neoplasm: Age, menstrual status, tumor size, ALN status, histological grade, pathological type, LVI status, ER level, PR level, and Ki-67 level were significantly different between the HER2-neg and HER2-pos-T groups (all P <  0.01, Table 1).